1 study on Poterepatide curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This discovery suggests HDM1005 could represent a significant advancement in treating metabolic disorders, potentially offering enhanced efficacy and a more convenient dosing schedule due to its extended half-life. Fo…